这是一篇来自已证抗体库的有关人类 血小板型选择素 (P-selectin) 的综述,是根据44篇发表使用所有方法的文章归纳的。这综述旨在帮助来邦网的访客找到最适合血小板型选择素 抗体。
血小板型选择素 同义词: CD62; CD62P; GMP140; GRMP; LECAM3; PADGEM; PSEL

BioLegend
小鼠 单克隆(AK4)
  • 流式细胞仪; 人类; 5:100
BioLegend血小板型选择素抗体(Biolegend, AK4)被用于被用于流式细胞仪在人类样本上浓度为5:100. elife (2021) ncbi
小鼠 单克隆(AK4)
  • 抑制或激活实验; 人类; 图 4b, 5b
BioLegend血小板型选择素抗体(BioLegend, 304902)被用于被用于抑制或激活实验在人类样本上 (图 4b, 5b). Nat Commun (2019) ncbi
小鼠 单克隆(AK4)
  • 流式细胞仪; 人类; 图 2e
BioLegend血小板型选择素抗体(Biolegend, 304918)被用于被用于流式细胞仪在人类样本上 (图 2e). Thromb Res (2018) ncbi
小鼠 单克隆(AK4)
  • 流式细胞仪; 人类; 图 2a
BioLegend血小板型选择素抗体(BioLegend, AK4)被用于被用于流式细胞仪在人类样本上 (图 2a). Thromb Res (2017) ncbi
小鼠 单克隆(AK4)
  • 流式细胞仪; 人类; 图 1d
BioLegend血小板型选择素抗体(Biolegend, AK4)被用于被用于流式细胞仪在人类样本上 (图 1d). Thromb Res (2016) ncbi
小鼠 单克隆(AK4)
  • 流式细胞仪; 人类; 图 1
BioLegend血小板型选择素抗体(Biolegend, 304906)被用于被用于流式细胞仪在人类样本上 (图 1). Nat Commun (2016) ncbi
小鼠 单克隆(AK4)
BioLegend血小板型选择素抗体(BioLegend, 304908)被用于. PLoS ONE (2015) ncbi
小鼠 单克隆(AK4)
  • 流式细胞仪; 人类; 图 4
BioLegend血小板型选择素抗体(Biolegend, 304910)被用于被用于流式细胞仪在人类样本上 (图 4). J Neuroinflammation (2015) ncbi
艾博抗(上海)贸易有限公司
domestic rabbit 多克隆
  • 免疫组化-冰冻切片; 小鼠; 图 1d
艾博抗(上海)贸易有限公司血小板型选择素抗体(Abcam, ab59738)被用于被用于免疫组化-冰冻切片在小鼠样本上 (图 1d). Cell Metab (2021) ncbi
domestic rabbit 单克隆(EPR22850-190)
  • 免疫组化-石蜡切片; 小鼠; 1:500; 图 1f
艾博抗(上海)贸易有限公司血小板型选择素抗体(Abcam, ab255822)被用于被用于免疫组化-石蜡切片在小鼠样本上浓度为1:500 (图 1f). Theranostics (2021) ncbi
小鼠 单克隆(AK-6)
  • 流式细胞仪; 人类; 图 4a
艾博抗(上海)贸易有限公司血小板型选择素抗体(Abcam, AK6)被用于被用于流式细胞仪在人类样本上 (图 4a). Res Pract Thromb Haemost (2020) ncbi
小鼠 单克隆(AK-6)
  • 免疫组化-冰冻切片; 小鼠; 1:100; 图 2d
艾博抗(上海)贸易有限公司血小板型选择素抗体(Abcam, ab6632)被用于被用于免疫组化-冰冻切片在小鼠样本上浓度为1:100 (图 2d). Nat Commun (2019) ncbi
赛默飞世尔
小鼠 单克隆(Psel.KO2.3)
  • 流式细胞仪; 小鼠
赛默飞世尔血小板型选择素抗体(eBioScience, 17-0626-80)被用于被用于流式细胞仪在小鼠样本上. Science (2020) ncbi
小鼠 单克隆(Psel.KO2.3)
  • 流式细胞仪; 小鼠; 图 3b
赛默飞世尔血小板型选择素抗体(eBioscience, 85-12-0626-80)被用于被用于流式细胞仪在小鼠样本上 (图 3b). Nat Commun (2017) ncbi
小鼠 单克隆(Psel.KO2.3)
  • 流式细胞仪; 小鼠; 表 s1
赛默飞世尔血小板型选择素抗体(eBioscience, 12-0626-82)被用于被用于流式细胞仪在小鼠样本上 (表 s1). J Clin Invest (2017) ncbi
小鼠 单克隆(Psel.KO2.3)
  • 流式细胞仪; 小鼠; 图 s6d
赛默飞世尔血小板型选择素抗体(eBioscience, Psel.KO2.3)被用于被用于流式细胞仪在小鼠样本上 (图 s6d). Nature (2017) ncbi
小鼠 单克隆(AK-4)
  • 酶联免疫吸附测定; 人类; 图 2d
赛默飞世尔血小板型选择素抗体(eBioscience, 14-0628)被用于被用于酶联免疫吸附测定在人类样本上 (图 2d). Sci Rep (2016) ncbi
小鼠 单克隆(AK-6)
  • 流式细胞仪; 人类; 图 6
赛默飞世尔血小板型选择素抗体(Thermo Scientific, AK-6)被用于被用于流式细胞仪在人类样本上 (图 6). J Mater Sci Mater Med (2016) ncbi
小鼠 单克隆(CRC81)
  • 流式细胞仪; 人类; 图 8
赛默飞世尔血小板型选择素抗体(Invitrogen, MHCD6204)被用于被用于流式细胞仪在人类样本上 (图 8). J Cell Biochem (2010) ncbi
圣克鲁斯生物技术
小鼠 单克隆(CTB201)
  • 免疫印迹; 小鼠; 图 2i
圣克鲁斯生物技术血小板型选择素抗体(Santa, sc-8419)被用于被用于免疫印迹在小鼠样本上 (图 2i). Adv Sci (Weinh) (2021) ncbi
小鼠 单克隆(CTB201)
  • 免疫细胞化学; 人类; 1:500; 图 3
圣克鲁斯生物技术血小板型选择素抗体(Santa Cruz, sc-8419)被用于被用于免疫细胞化学在人类样本上浓度为1:500 (图 3). J Lipid Res (2018) ncbi
小鼠 单克隆(CTB201)
  • 免疫细胞化学; 人类; 图 5d
圣克鲁斯生物技术血小板型选择素抗体(SantaCruz, CTB201)被用于被用于免疫细胞化学在人类样本上 (图 5d). J Clin Invest (2017) ncbi
小鼠 单克隆(CTB201)
  • 抑制或激活实验; 人类; 图 6c
圣克鲁斯生物技术血小板型选择素抗体(SantaCruz, sc-8419)被用于被用于抑制或激活实验在人类样本上 (图 6c). Front Immunol (2016) ncbi
小鼠 单克隆(1 E 3)
  • 免疫组化-石蜡切片; 人类; 图 4
圣克鲁斯生物技术血小板型选择素抗体(Santa Cruz Biotechnology, 1E3)被用于被用于免疫组化-石蜡切片在人类样本上 (图 4). J Exp Med (2014) ncbi
伯乐(Bio-Rad)公司
小鼠 单克隆(Psel.KO.2.12)
  • 流式细胞仪; 人类
伯乐(Bio-Rad)公司血小板型选择素抗体(Serotec, MCA2420PE)被用于被用于流式细胞仪在人类样本上. Nanomedicine (2015) ncbi
小鼠 单克隆(Psel.KO.2.7)
  • 流式细胞仪; 家羊; 图 3
伯乐(Bio-Rad)公司血小板型选择素抗体(AbD Serotec, MCA2419)被用于被用于流式细胞仪在家羊样本上 (图 3). ASAIO J (2014) ncbi
小鼠 单克隆(Psel.KO.2.5)
  • 流式细胞仪; 家羊; 图 3
伯乐(Bio-Rad)公司血小板型选择素抗体(AbD Serotec, MCA2418)被用于被用于流式细胞仪在家羊样本上 (图 3). ASAIO J (2014) ncbi
小鼠 单克隆(AK-6)
  • 免疫组化-石蜡切片; 人类; 1:4000
伯乐(Bio-Rad)公司血小板型选择素抗体(AbD serotec, MCA796GA)被用于被用于免疫组化-石蜡切片在人类样本上浓度为1:4000. Int J Cardiol (2013) ncbi
小鼠 单克隆(Psel.KO.2.7)
  • 流式细胞仪; 人类
  • 流式细胞仪; 牛
伯乐(Bio-Rad)公司血小板型选择素抗体(AbD Serotec, MCA2419PE)被用于被用于流式细胞仪在人类样本上 和 被用于流式细胞仪在牛样本上. Artif Organs (2013) ncbi
小鼠 单克隆(AK-6)
  • 免疫细胞化学; 人类; 1:100
伯乐(Bio-Rad)公司血小板型选择素抗体(Serotec, MCA796GA)被用于被用于免疫细胞化学在人类样本上浓度为1:100. Biomaterials (2012) ncbi
小鼠 单克隆(AK-6)
  • 免疫细胞化学; 人类; 1:100
伯乐(Bio-Rad)公司血小板型选择素抗体(Serotec Co, MCA796GA)被用于被用于免疫细胞化学在人类样本上浓度为1:100. J Biomed Mater Res A (2012) ncbi
小鼠 单克隆(AK-6)
  • 免疫细胞化学; 人类; 1:100
伯乐(Bio-Rad)公司血小板型选择素抗体(Serotec Co, MCA796GA)被用于被用于免疫细胞化学在人类样本上浓度为1:100. J Biomed Mater Res A (2012) ncbi
LifeSpan Biosciences
domestic rabbit 多克隆
  • 免疫组化-石蜡切片; 小鼠; 图 1g
LifeSpan Biosciences血小板型选择素抗体(LSBio, LS-B3578)被用于被用于免疫组化-石蜡切片在小鼠样本上 (图 1g). Cell (2020) ncbi
碧迪BD
小鼠 单克隆(AK-4)
  • 流式细胞仪; 人类; 1:20; 图 3a
碧迪BD血小板型选择素抗体(BD Biosciences, 550888)被用于被用于流式细胞仪在人类样本上浓度为1:20 (图 3a). Nat Commun (2018) ncbi
小鼠 单克隆(AK-4)
  • 流式细胞仪; 小鼠; 图 2b
碧迪BD血小板型选择素抗体(BD Pharmingen, AK-4)被用于被用于流式细胞仪在小鼠样本上 (图 2b). Sci Immunol (2018) ncbi
小鼠 单克隆(AK-4)
  • 其他; 人类; 图 s1
碧迪BD血小板型选择素抗体(BD/Pharm, 551345)被用于被用于其他在人类样本上 (图 s1). Cell Chem Biol (2017) ncbi
小鼠 单克隆(AC1.2)
  • 流式细胞仪; African green monkey; 图 7
碧迪BD血小板型选择素抗体(BD Biosciences, 550561)被用于被用于流式细胞仪在African green monkey样本上 (图 7). J Biol Chem (2017) ncbi
小鼠 单克隆(AK-4)
  • 流式细胞仪; 人类; 图 1a
碧迪BD血小板型选择素抗体(BD Biosciences, AK-4)被用于被用于流式细胞仪在人类样本上 (图 1a). Vox Sang (2016) ncbi
小鼠 单克隆(AK-4)
  • 流式细胞仪; 人类; 图 st1
碧迪BD血小板型选择素抗体(BD, 555524)被用于被用于流式细胞仪在人类样本上 (图 st1). Exp Cell Res (2016) ncbi
小鼠 单克隆(AK-4)
  • 流式细胞仪; 人类
碧迪BD血小板型选择素抗体(BD Biosciences, 555524)被用于被用于流式细胞仪在人类样本上. Mar Drugs (2015) ncbi
小鼠 单克隆(AC1.2)
  • 流式细胞仪; 人类
碧迪BD血小板型选择素抗体(BD, 348107)被用于被用于流式细胞仪在人类样本上. Thromb Res (2015) ncbi
小鼠 单克隆(AK-4)
  • 流式细胞仪; 人类; 1:25; 图 1
碧迪BD血小板型选择素抗体(BD Biosciences, 555523)被用于被用于流式细胞仪在人类样本上浓度为1:25 (图 1). Biogerontology (2015) ncbi
小鼠 单克隆(AK-4)
  • 流式细胞仪; 人类
碧迪BD血小板型选择素抗体(BD Biosciences, AK-4)被用于被用于流式细胞仪在人类样本上. J Thromb Haemost (2015) ncbi
小鼠 单克隆(AK-4)
  • 流式细胞仪; 小鼠
碧迪BD血小板型选择素抗体(BD Biosciences, Clone AK-4)被用于被用于流式细胞仪在小鼠样本上. Transfusion (2014) ncbi
小鼠 单克隆(AK-4)
  • 流式细胞仪; 人类; 表 2
碧迪BD血小板型选择素抗体(BD Biosciences, 55524)被用于被用于流式细胞仪在人类样本上 (表 2). PLoS ONE (2012) ncbi
文章列表
  1. Fan Z, Turiel G, Ardicoglu R, Ghobrial M, Masschelein E, Kocijan T, et al. Exercise-induced angiogenesis is dependent on metabolically primed ATF3/4+ endothelial cells. Cell Metab. 2021;: pubmed 出版商
  2. Qin Z, Liu F, Blair R, Wang C, Yang H, Mudd J, et al. Endothelial cell infection and dysfunction, immune activation in severe COVID-19. Theranostics. 2021;11:8076-8091 pubmed 出版商
  3. Tan H, Song Y, Chen J, Zhang N, Wang Q, Li Q, et al. Platelet-Like Fusogenic Liposome-Mediated Targeting Delivery of miR-21 Improves Myocardial Remodeling by Reprogramming Macrophages Post Myocardial Ischemia-Reperfusion Injury. Adv Sci (Weinh). 2021;8:e2100787 pubmed 出版商
  4. Chioh F, Fong S, Young B, Wu K, Siau A, Krishnan S, et al. Convalescent COVID-19 patients are susceptible to endothelial dysfunction due to persistent immune activation. elife. 2021;10: pubmed 出版商
  5. Ruscetti M, Morris J, Mezzadra R, Russell J, Leibold J, Romesser P, et al. Senescence-Induced Vascular Remodeling Creates Therapeutic Vulnerabilities in Pancreas Cancer. Cell. 2020;181:424-441.e21 pubmed 出版商
  6. Moroi M, Farndale R, Jung S. Activation-induced changes in platelet surface receptor expression and the contribution of the large-platelet subpopulation to activation. Res Pract Thromb Haemost. 2020;4:285-297 pubmed 出版商
  7. Cserép C, Pósfai B, Lénárt N, Fekete R, László Z, Lele Z, et al. Microglia monitor and protect neuronal function through specialized somatic purinergic junctions. Science. 2020;367:528-537 pubmed 出版商
  8. Bertrand L, Méroth F, Tournebize M, Leda A, Sun E, Toborek M. Targeting the HIV-infected brain to improve ischemic stroke outcome. Nat Commun. 2019;10:2009 pubmed 出版商
  9. Perdomo J, Leung H, Ahmadi Z, Yan F, Chong J, Passam F, et al. Neutrophil activation and NETosis are the major drivers of thrombosis in heparin-induced thrombocytopenia. Nat Commun. 2019;10:1322 pubmed 出版商
  10. Loelius S, Lannan K, Blumberg N, Phipps R, Spinelli S. The HIV protease inhibitor, ritonavir, dysregulates human platelet function in vitro. Thromb Res. 2018;169:96-104 pubmed 出版商
  11. Pircher J, Czermak T, Ehrlich A, Eberle C, Gaitzsch E, Margraf A, et al. Cathelicidins prime platelets to mediate arterial thrombosis and tissue inflammation. Nat Commun. 2018;9:1523 pubmed 出版商
  12. Beutier H, Hechler B, Godon O, Wang Y, Gillis C, de Chaisemartin L, et al. Platelets expressing IgG receptor FcγRIIA/CD32A determine the severity of experimental anaphylaxis. Sci Immunol. 2018;3: pubmed 出版商
  13. Hartman C, Duerr M, Albert C, Neumann W, McHowat J, Ford D. 2-Chlorofatty acids induce Weibel-Palade body mobilization. J Lipid Res. 2018;59:113-122 pubmed 出版商
  14. Hally K, La Flamme A, Larsen P, Harding S. Platelet Toll-like receptor (TLR) expression and TLR-mediated platelet activation in acute myocardial infarction. Thromb Res. 2017;158:8-15 pubmed 出版商
  15. Shah F, Stepan A, O Mahony A, Velichko S, Folias A, Houle C, et al. Mechanisms of Skin Toxicity Associated with Metabotropic Glutamate Receptor 5 Negative Allosteric Modulators. Cell Chem Biol. 2017;24:858-869.e5 pubmed 出版商
  16. Qiu C, Wang Y, Zhao H, Qin L, Shi Y, Zhu X, et al. The critical role of SENP1-mediated GATA2 deSUMOylation in promoting endothelial activation in graft arteriosclerosis. Nat Commun. 2017;8:15426 pubmed 出版商
  17. Kraakman M, Lee M, Al Sharea A, Dragoljevic D, Barrett T, Montenont E, et al. Neutrophil-derived S100 calcium-binding proteins A8/A9 promote reticulated thrombocytosis and atherogenesis in diabetes. J Clin Invest. 2017;127:2133-2147 pubmed 出版商
  18. Lefrançais E, Ortiz Muñoz G, Caudrillier A, Mallavia B, Liu F, Sayah D, et al. The lung is a site of platelet biogenesis and a reservoir for haematopoietic progenitors. Nature. 2017;544:105-109 pubmed 出版商
  19. Hayes V, Johnston I, Arepally G, McKenzie S, Cines D, Rauova L, et al. Endothelial antigen assembly leads to thrombotic complications in heparin-induced thrombocytopenia. J Clin Invest. 2017;127:1090-1098 pubmed 出版商
  20. Liu L, Jacobsen F, Everds N, Zhuang Y, Yu Y, Li N, et al. Biological Characterization of a Stable Effector Functionless (SEFL) Monoclonal Antibody Scaffold in Vitro. J Biol Chem. 2017;292:1876-1883 pubmed 出版商
  21. Pepin M, Mezouar S, Pegon J, Muczynski V, Adam F, Bianchini E, et al. Soluble Siglec-5 associates to PSGL-1 and displays anti-inflammatory activity. Sci Rep. 2016;6:37953 pubmed 出版商
  22. Pieterse E, Rother N, Yanginlar C, Hilbrands L, van der Vlag J. Neutrophils Discriminate between Lipopolysaccharides of Different Bacterial Sources and Selectively Release Neutrophil Extracellular Traps. Front Immunol. 2016;7:484 pubmed
  23. Hally K, La Flamme A, Larsen P, Harding S. Toll-like receptor 9 expression and activation in acute coronary syndrome patients on dual anti-platelet therapy. Thromb Res. 2016;148:89-95 pubmed 出版商
  24. Deng W, Xu Y, Chen W, Paul D, Syed A, Dragovich M, et al. Platelet clearance via shear-induced unfolding of a membrane mechanoreceptor. Nat Commun. 2016;7:12863 pubmed 出版商
  25. Rijkers M, van der Meer P, Bontekoe I, Daal B, de Korte D, Leebeek F, et al. Evaluation of the role of the GPIb-IX-V receptor complex in development of the platelet storage lesion. Vox Sang. 2016;111:247-256 pubmed 出版商
  26. Lakschevitz F, Hassanpour S, Rubin A, Fine N, Sun C, Glogauer M. Identification of neutrophil surface marker changes in health and inflammation using high-throughput screening flow cytometry. Exp Cell Res. 2016;342:200-9 pubmed 出版商
  27. Wang J, Xiong G, Luo B, Choo C, Yuan S, Tan N, et al. Surface modification of PVDF using non-mammalian sources of collagen for enhancement of endothelial cell functionality. J Mater Sci Mater Med. 2016;27:45 pubmed 出版商
  28. Hyvärinen S, Jokiranta T. Minor Role of Plasminogen in Complement Activation on Cell Surfaces. PLoS ONE. 2015;10:e0143707 pubmed 出版商
  29. Ampofo E, Später T, Müller I, Eichler H, Menger M, Laschke M. The Marine-Derived Kinase Inhibitor Fascaplysin Exerts Anti-Thrombotic Activity. Mar Drugs. 2015;13:6774-91 pubmed 出版商
  30. Granja T, Schad J, Schüssel P, Fischer C, Häberle H, Rosenberger P, et al. Using six-colour flow cytometry to analyse the activation and interaction of platelets and leukocytes--A new assay suitable for bench and bedside conditions. Thromb Res. 2015;136:786-96 pubmed 出版商
  31. O Carroll S, Kho D, Wiltshire R, Nelson V, Rotimi O, Johnson R, et al. Pro-inflammatory TNFα and IL-1β differentially regulate the inflammatory phenotype of brain microvascular endothelial cells. J Neuroinflammation. 2015;12:131 pubmed 出版商
  32. Plagg B, Marksteiner J, Kniewallner K, Humpel C. Platelet dysfunction in hypercholesterolemia mice, two Alzheimer's disease mouse models and in human patients with Alzheimer's disease. Biogerontology. 2015;16:543-58 pubmed 出版商
  33. Negrotto S, Jaquenod de Giusti C, Rivadeneyra L, Ure A, Mena H, Schattner M, et al. Platelets interact with Coxsackieviruses B and have a critical role in the pathogenesis of virus-induced myocarditis. J Thromb Haemost. 2015;13:271-82 pubmed 出版商
  34. Schneider Hohendorf T, Rossaint J, Mohan H, Böning D, Breuer J, Kuhlmann T, et al. VLA-4 blockade promotes differential routes into human CNS involving PSGL-1 rolling of T cells and MCAM-adhesion of TH17 cells. J Exp Med. 2014;211:1833-46 pubmed 出版商
  35. Gaffney A, Santos Martinez M, Satti A, Major T, Wynne K, Gun ko Y, et al. Blood biocompatibility of surface-bound multi-walled carbon nanotubes. Nanomedicine. 2015;11:39-46 pubmed 出版商
  36. Shankarraman V, Kocyildirim E, Olia S, Kameneva M, Dzadony R, Maul T, et al. Biocompatibility Assessment of the CentriMag-Novalung Adult ECMO Circuit in a Model of Acute Pulmonary Hypertension. ASAIO J. 2014;60:429-35 pubmed 出版商
  37. Takahashi S, Suzuki K, Watanabe Y, Watanabe K, Fujioka D, Nakamura T, et al. Phospholipase A2 expression in coronary thrombus is increased in patients with recurrent cardiac events after acute myocardial infarction. Int J Cardiol. 2013;168:4214-21 pubmed 出版商
  38. Lu Q, Hofferbert B, Koo G, Malinauskas R. In vitro shear stress-induced platelet activation: sensitivity of human and bovine blood. Artif Organs. 2013;37:894-903 pubmed 出版商
  39. Chi X, Zhi L, Vostal J. Human platelets pathogen reduced with riboflavin and ultraviolet light do not cause acute lung injury in a two-event SCID mouse model. Transfusion. 2014;54:74-85 pubmed 出版商
  40. Yang Z, Tu Q, Maitz M, Zhou S, Wang J, Huang N. Direct thrombin inhibitor-bivalirudin functionalized plasma polymerized allylamine coating for improved biocompatibility of vascular devices. Biomaterials. 2012;33:7959-71 pubmed 出版商
  41. Yang Z, Zhou S, Lu L, Wang X, Wang J, Huang N. Construction and hemocompatibility study of highly bioactive heparin-functionalized surface. J Biomed Mater Res A. 2012;100:3124-33 pubmed 出版商
  42. Kim S, Moon G, Cho Y, Kang H, Hyung N, Kim D, et al. Circulating mesenchymal stem cells microparticles in patients with cerebrovascular disease. PLoS ONE. 2012;7:e37036 pubmed 出版商
  43. Lu L, Li Q, Maitz M, Chen J, Huang N. Immobilization of the direct thrombin inhibitor-bivalirudin on 316L stainless steel via polydopamine and the resulting effects on hemocompatibility in vitro. J Biomed Mater Res A. 2012;100:2421-30 pubmed 出版商
  44. Kuzelova K, Pluskalova M, Grebeňová D, Pavlaskova K, Halada P, Hrkal Z. Changes in cell adhesivity and cytoskeleton-related proteins during imatinib-induced apoptosis of leukemic JURL-MK1 cells. J Cell Biochem. 2010;111:1413-25 pubmed 出版商